Healthy Skepticism Library item: 7933

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Morris L.
DTC & Rx costs: circumstantial case
Pharmaceutical Executive 1999 Sep; 19:20

Abstract:

An argument on whether direct to consumer (DTC) advertising is an important factor in rising drug costs is presented, including an examination of whether prescription expenditures have increased as a result of higher medication prices or because of a larger patient population, and a consideration of whether increases in drug expenditures by DTC advertising are a public good or a public detriment.